국내 미도입 파킨슨병 치료 약물과 그 문제점 / 고대안산병원 신경과 권도영

For Parkinson's patients and their families, news of new treatments is a source of fervent hope. However, were you aware that there are drugs that have not yet been introduced to Korea for various reasons, despite already being recognized for their effectiveness and widely used overseas? In today's live broadcast, we are joined by Professor Do-Young Kwon from the Department of Neurology at Korea University Ansan Hospital to delve deeply into which of the latest Parkinson's treatments are currently unavailable in Korea, and to examine the institutional issues and practical limitations behind the delays in their introduction. Check out the latest insights on Parkinson's treatment, and if you have any questions that have been bothering you, please leave your questions in real-time during today's broadcast. #AfterTheRain #KoreaUniversityAnsanHospital #Neurology #KwonDoYoung #ParkinsonsDisease #ParkinsonsDiseaseTreatment #NewDrugIntroduction #MedicalPolicy #NeurologicalDisorders #HealthInformation Producers: PD Lee Myung-jin, Director Kim Jun-heon With the hope that all citizens can take good nutritional supplements without any financial burden, After The Rain supports Esther Formula's National Nutrition Project 🤍 Starting from 8,900 won per month — Choose the supplements your body needs 👉 https://iff.do/4XN [Pre-broadcast Q&A Guide] Please leave any questions or inquiries regarding the live broadcast on the official After The Rain website. After The Rain Website: http://aftertherain.kr [Important Notice] This video is intended to convey information through knowledge sharing and cannot, under any circumstances, replace medical consultation. After The Rain produces this broadcast without any financial support from the participating hospitals.